SUPRIYA

Supriya Lifescience Ltd (SUPRIYA) Q3 2026 Earnings Call Transcript

3 weeks ago

Supriya Lifescience Ltd (NSE: SUPRIYA) Q3 2026 Earnings Call dated Feb. 10, 2026 Corporate Participants: Ms. Neha Salian — Investor…

Supriya Lifescience Reports 11.2% Revenue Growth in Q3 FY26 Driven by Anesthetic Segment and Export Demand

3 weeks ago

Supriya Lifescience Limited (NSE: SUPRIYA) the active pharmaceutical ingredient manufacturer recorded increased top-line performance supported by higher capacity utilization and…